LogunovDYDolzhikovaIVShcheblyakovDV, et al. Safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine: an interim analysis of a randomized controlled phase 3 trial in Russia. Lancet2021; 397: 671–681.
2.
VasilyevPChirkovaAPetrenkoA.Testing meldonium: assessing Soviet pragmatic alternatives to the randomized controlled trial. Clin Trials2021.
3.
WittesJ.Commentary on Chirkova et al: some comments on socialist pharmapolitics. Clin Trials2021.
4.
NurkhametovaDKaramGZiganshinaL.Registration of clinical trials in Russia: how does it compare with the WHO ICTRP standards?Clin Trials2021.
